首页> 外文期刊>BJU international >Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma.
【24h】

Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma.

机译:错配修复基因hMLH1和hMSH2在散发性肾细胞癌患者中的意义。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To analyse the implications of DNA mismatch repair genes hMLH1 and hMSH2 in sporadic renal cell carcinoma (RCC). MATERIALS AND METHODS: Specimens of tumour and healthy renal tissue were collected from 89 patients treated for sporadic RCC. Another 95 blood samples taken from individuals with no history of cancer were also analysed. After DNA extraction and PCR amplification, microsatellite instability (MSI) was determined using the Bethesda microsatellite panel, two exonic microsatellites of the TGFbRII and BAX genes, and the microsatellite D3S1611. The promoter methylation status of hMLH1 was investigated using the HpaII and MspI restriction enzymes. In addition, a sequencing analysis of complete coding region of hMLH1 and hMSH2 genes was performed. RESULTS: MSI and promoter hypermethylation of hMLH1 were not detected. Interestingly, loss of heterozygosity (LOH) was common among patients with RCC, particularly in microsatellite D3S1611 (34.9%). Mutations were identified in eight patients: K618A and V716M in gene hMLH1; and I145V, G322D, and the novel mutation P349A, in gene hMSH2. The mutations also appeared in healthy renal tissue and therefore, were considered as germline DNA sequence variations. There were G322D and K618A changes in 1% of the healthy control subjects, suggesting that they are DNA polymorphisms. CONCLUSIONS: Our data show that loss of function of both hMLH1 and hMSH2 is not involved in sporadic RCC, either by promoter methylation or mutation in their exons. However, LOH indicated that chromosomal instability affecting large fragments of DNA was the main genetic alteration we detected associated with RCC.
机译:目的:分析DNA错配修复基因hMLH1和hMSH2在散发性肾细胞癌(RCC)中的意义。材料与方法:从89例接受散发性RCC的患者中收集肿瘤和健康的肾组织标本。还分析了另外95份无癌症史个体的血液样本。 DNA提取和PCR扩增后,使用Bethesda微卫星面板,两个TGFbRII和BAX基因外显子微卫星以及D3S1611微卫星确定微卫星不稳定性(MSI)。使用HpaII和MspI限制酶研究了hMLH1的启动子甲基化状态。另外,对hMLH1和hMSH2基因的完整编码区进行了测序分析。结果:未检测到hMLH1的MSI和启动子高甲基化。有趣的是,RCC患者中杂合子丢失(LOH)很常见,特别是在微卫星D3S1611中(34.9%)。在八名患者中发现了突变:hMLH1基因中的K618A和V716​​M; hMSH2基因中的I145V,G322D和新突变P349A。该突变也出现在健康的肾脏组织中,因此被认为是种系DNA序列变异。在健康对照受试者中,> 1%的受试者发生了G322D和K618A变化,表明它们是DNA多态性。结论:我们的数据表明,hMLH1和hMSH2的功能丧失均不涉及散发性RCC,无论是通过启动子甲基化还是其外显子突变。但是,LOH表明影响大片段DNA的染色体不稳定性是我们检测到的与RCC相关的主要遗传改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号